U.S. GOVERNMENT PUBLISHING OFFICE

WASHINGTON : 

1 

79–010 

" ! SENATE 115TH CONGRESS

2d Session 

REPORT

2018

115–286 

Calendar No. 491 

FIGHTING OPIOID ABUSE IN 

TRANSPORTATION ACT 

R E P O R T 

OF THE

COMMITTEE ON COMMERCE, SCIENCE, AND 

TRANSPORTATION 

ON

S. 2848 

JUNE 27, 2018.—Ordered to be printed 


congress.#13
(II) 

SENATE COMMITTEE ON COMMERCE, SCIENCE, AND TRANSPORTATION 

ONE HUNDRED FIFTEENTH CONGRESS

SECOND SESSION

JOHN THUNE, South Dakota, Chairman 

ROGER F. WICKER, Mississippi BILL NELSON, Florida 

ROY BLUNT, Missouri MARIA CANTWELL, Washington 

TED CRUZ, Texas AMY KLOBUCHAR, Minnesota 

DEB FISCHER, Nebraska RICHARD BLUMENTHAL, Connecticut 

JERRY MORAN, Kansas BRIAN SCHATZ, Hawaii 

DAN SULLIVAN, Alaska EDWARD J. MARKEY, Massachusetts 

DEAN HELLER, Nevada TOM UDALL, New Mexico 

JAMES M. INHOFE, Oklahoma GARY C. PETERS, Michigan 

MIKE LEE, Utah TAMMY BALDWIN, Wisconsin 

RON JOHNSON, Wisconsin TAMMY DUCKWORTH, Illinois 

SHELLEY MOORE CAPITO, West Virginia MARGARET WOOD HASSAN, New Hampshire 

CORY GARDNER, Colorado CATHERINE CORTEZ MASTO, Nevada 

TODD C. YOUNG, Indiana JON TESTER, Montana 

NICK ROSSI, Staff Director 

ADRIAN ARNAKIS, Deputy Staff Director 

JASON VAN BEEK, General Counsel 

KIM LIPSKY, Democratic Staff Director 

CHRISTOPHER DAY, Democratic Deputy Staff Director 

1 National Institute on Drug Abuse. Nearly half of opioid-related overdose deaths involve 

fentanyl. 2018. (https://www.drugabuse.gov/news-events/news-releases/2018/05/nearly-halfopioid-related-overdose-deaths-involve-fentanyl) 

Calendar No. 491 

115TH CONGRESS REPORT " ! SENATE 2d Session 115–286 

FIGHTING OPIOID ABUSE IN TRANSPORTATION ACT 

JUNE 27, 2018.—Ordered to be printed 

Mr. THUNE, from the Committee on Commerce, Science, and 

Transportation, submitted the following 

R E P O R T 

[To accompany S. 2848] 

[Including cost estimate of the Congressional Budget Office] 

The Committee on Commerce, Science, and Transportation, to 

which was referred the bill (S. 2848) to improve Department of 

Transportation controlled substances and alcohol testing, and for 

other purposes, having considered the same, reports favorably 

thereon with an amendment (in the nature of a substitute) and recommends that the bill (as amended) do pass. 

PURPOSE OF THE BILL

The purpose of S. 2848 is to improve drug and alcohol testing requirements for transportation workers by doing the following: extending testing requirements to rail mechanical employees and 

yardmasters; setting a deadline for the issuance of oral fluid testing guidelines; increasing the transparency of drug and alcohol 

testing data; promoting accountability for the issuance of regulatory actions required by prior statutes; and requiring mandatory 

testing guidelines to include fentanyl on the drug testing panel if 

justified. 

BACKGROUND AND NEEDS

Opioid abuse has surged in recent years, with more than 42,000 

opioid overdose deaths in 2016 alone.1 Opioid abuse negatively affects transportation safety; recent post-accident test data show sigVerDate Sep 11 2014 06:41 Jun 28, 2018 Jkt 079010 PO 00000 Frm 00003 Fmt 6659 Sfmt 6602 E:\HR\OC\SR286.XXX SR286
2 

2Governors’ Highway Safety Association. Drug-Impaired Driving: Marijuana and Opioids 

Raise Critical Issues for States. 2018. (https://www.ghsa.org/resources/DUID18) 3Federal Railroad Administration. MOW Final Rule Presentation; Drug & Alcohol Regulations, Incidents, and Trends. September 15, 2016. (https://rsac.fra.dot.gov/meetings/ 

20160915.php) 4DOT. Office of Drug and Alcohol Policy and Compliance. Employees—What are the drug & 

alcohol testing rules and where do I find them? 2018. (https://www.transportation.gov/odapc/employee). Note that this number includes employees subject to regulations of the United States 

Coast Guard, which is part of the Department of Homeland Security. 5See Omnibus Transportation Employee Testing Act of 1991 (P.L. 102–143). 

6SAMHSA. Mandatory Guidelines for Federal Workplace Drug Testing Programs. 2017. 

(https://www.samhsa.gov/sites/default/files/workplace/frn_vol_82_7920_.pdf) 7DOT. Addition of Certain Schedule II Drugs to the Department of Transportation’s DrugTesting Panel and Certain Minor Amendments. 2017. (https://www.federalregister.gov/ 

documents/2017/11/13/2017-24397/procedures-for-transportation-workplace-drug-and-alcoholtesting-programs-addition-of-certain) 8 Ibid. National Institute on Drug Abuse. 2018. 

9Federal Railroad Administration. Drug and Alcohol. 2018. (https://www.fra.dot.gov/Page/ 

P0345) 

nificant increases in the number of operators or drivers impaired 

by opioids and involved in accidents.2 In addition, lab-reported Department of Transportation (DOT) drug testing data for safety-sensitive transportation workers from 2011 to 2015 show increases in 

positive drug tests across a range of substances, including opiates 

and amphetamines.3 DOT, through its Office of Drug and Alcohol 

Policy and Compliance (ODAPC) and modal administrations, currently requires drug and alcohol testing for more than 12 million 

transportation workers in the aviation, trucking, railroad, mass 

transit, pipeline, and other transportation industries.4

Pursuant to the Omnibus Transportation Employee Testing Act 

of 1991 (P.L. 102–143), DOT follows the Department of Health and 

Human Services (HHS) Mandatory Guidelines for Federal Workplace Drug Testing Programs (HHS Mandatory Guidelines) to determine the types of drugs for which DOT requires testing.5 DOT, 

however, has discretion regarding many aspects of the regulations 

covering regulated modal administration programs, and ODAPC 

primarily advises DOT on such issues, publishing drug and alcohol 

testing regulations for the transportation industry and issuing official interpretations of those regulations. 

On January 23, 2017, HHS revised its HHS Mandatory Guidelines to include synthetic opioids—specifically oxycodone, 

oxymorphone, hydrocodone, and hydromorphone—on the panel of 

controlled substances for which Federal agencies can test.6 Following revision of the HHS Mandatory Guidelines, on November 

13, 2017, DOT published a final rule including these synthetic 

opioids on its drug testing panel used for transportation workers 

subject to DOT drug and alcohol testing regulations.7 Notably, 

fentanyl, a synthetic opioid responsible for approximately 19,000, 

or 46 percent, of the opioid overdose deaths in 2016, was not included on the panel.8

Like many transportation workers across modes, railroad employees defined as performing safety-sensitive functions—including 

engineers, conductors, brakemen, dispatching employees, and signal employees, among other types of employees—are subject to 

mandatory drug and alcohol testing.9 The goal of this testing is to 

serve as a deterrent for drug and alcohol use, reducing on-the-job 

impairment and therefore increasing safety. However, rail mechanical employees and yardmasters, who do not perform a dual role 

that otherwise would require testing, are currently not subject to 

mandatory drug and alcohol testing, despite the nexus between 

3 

10FAST Act Section 5402 (codified at 49 U.S.C. § 31306 note). 11SAMHSA. Request for Information Regarding Specific Issues Related to the Use of the Hair 

Specimen for Drug Testing. 2015. (https://www.gpo.gov/fdsys/pkg/FR-2015-05-29/pdf/2015- 

12743.pdf) 12SAMHSA. Mandatory Guidelines for Federal Workplace Drug Testing Programs. 2015. 

(https://www.gpo.gov/fdsys/pkg/FR-2015-05-15/pdf/2015-11523.pdf) 13 Information Provided by the Office of Drug and Alcohol Policy and Compliance. 14P.L. 112–141. 15Federal Motor Carrier Safety Administration. Commercial Driver’s License Drug and Alcohol Clearinghouse. 2016. (https://www.gpo.gov/fdsys/pkg/FR-2016-12-05/pdf/2016-27398.pdf) 

their work and safety. Moreover, because transit and aviation mechanical employees are generally subject to mandatory drug and alcohol testing requirements, extending requirements to rail mechanical employees and yardmasters would increase uniformity in the 

types of employees tested across modes of transportation. 

While urine, oral fluid, and hair can also be used to test for concentrations of controlled substances, urine testing currently is the 

only form of drug testing authorized for use under the HHS Mandatory Guidelines. Hair and oral fluid testing may offer advantages 

in comparison to urine testing, including more expedient and less 

invasive testing procedures, and hair testing may offer greater visibility on use patterns. The Fixing America’s Surface Transportation 

(FAST) Act (P.L. 114–94) required HHS to issue, not later than 1 

year after the date of enactment, guidelines for hair testing as a 

method of detecting use of a controlled substance.10 However, HHS 

to date has only issued a request for information on hair testing, 

released in May 2015, before the enactment of the FAST Act.11

HHS also issued a notice of mandatory guidelines for oral fluid 

testing in May 2015, but it has yet to finalize these guidelines.12

Given the number of tests conducted across the transportation 

industry, about 6 million tests annually, better data collection and 

analysis in relation to drug and alcohol testing provides valuable 

insight regarding changes in the types of substances used and magnitude of positive test rates.13 However, DOT currently does not 

have a consolidated, publicly accessible database to display drug 

and alcohol testing across modes of transportation and by drug 

type, among other variables. Moreover, DOT does not have a national database for regulators and employers to track drug and alcohol violations and ensure that such drivers are identified before 

operating commercial motor vehicles on public roads. To that end, 

in 2012, Congress, in the Moving Ahead for Progress in the 21st 

Century Act (MAP–21; P.L. 112–141), directs the Secretary of 

Transportation to establish a national clearinghouse containing 

commercial motor vehicle operators’ violations of the Federal Motor 

Carrier Safety Administration’s (FMCSA) drug and alcohol testing 

program.14 On December 5, 2016, FMCSA published the final rule 

pursuant to the MAP–21 mandate and set a compliance date for 

January 6, 2020.15

SUMMARY OF PROVISIONS

If enacted, S. 2848 would do the following: 

• Close a safety gap in railroad drug and alcohol testing regulations by expanding testing requirements to both rail mechanical 

employees and yardmasters. 

4 

• Address a major on-going drug abuse issue by requiring that 

HHS and DOT include fentanyl in the drug-testing panel, subject 

to findings on available testing. 

• Advance a more expedient and less invasive testing method by 

setting a deadline for HHS to issue mandatory guidelines on oral 

fluid testing. 

• Increase transparency by requiring DOT to create a publicly 

available database of drug and alcohol testing data and requiring 

the Government Accountability Office (GAO) to review DOT’s collection, use, and availability of drug and alcohol testing data. 

• Promote accountability by requiring FMCSA to provide status 

reports on its implementation of the Commercial Driver’s License 

Drug and Alcohol Clearinghouse and HHS to provide status reports 

on its hair testing guideline. 

LEGISLATIVE HISTORY

S. 2848 was introduced by Senator Thune on May 15, 2018. On 

May 22, 2018, in an open Executive Session, the Committee, by 

voice vote, ordered the bill to be reported favorably with an amendment (in the nature of a substitute). Senator Thune offered an 

amendment (in the nature of a substitute) to improve the bill. The 

Committee accepted the bill and amendment en bloc by voice vote. 

ESTIMATED COSTS

In accordance with paragraph 11(a) of rule XXVI of the Standing 

Rules of the Senate and section 403 of the Congressional Budget 

Act of 1974, the Committee provides the following cost estimate, 

prepared by the Congressional Budget Office: 

S. 2848—Fighting Opioid Abuse in Transportation Act 

The Department of Transportation (DOT) issues regulations concerning drug and alcohol testing of workers in the transportation 

industry. The Department of Health and Human Services (HHS) 

issues guidelines concerning drug testing in federal workplaces. 

S. 2848 would require DOT and HHS to issue and revise regulations regarding who is subject to drug and alcohol testing and to 

report to the Congress regarding the implementation of previous 

regulations. The bill also would require DOT to establish a public 

database on drug and alcohol testing of employees in the transportation industry and to require the Governmental Accountability Office to complete a report. 

Under current law, DOT collects information from employers 

about the drug and alcohol testing of employees. S. 2848 also would 

require DOT to revise current rules about which categories of railroad employees are subject to drug and alcohol testing. CBO expects that to expand that information into a publicly available 

database, the agency would have to hire up to two employees over 

a three-year period (at an average annual cost of $125,000 per employee) to develop the database and to complete the required rulemaking and reports. 

HHS establishes the scientific and technical guidelines for federal drug-testing programs in the workplace. Current guidelines 

address testing for certain opioid drugs, but do not include testing 

for the synthetic opioid fentanyl. The bill would require HHS to upVerDate Sep 11 2014 06:41 Jun 28, 2018 Jkt 079010 PO 00000 Frm 00006 Fmt 6659 Sfmt 6602 E:\HR\OC\SR286.XXX SR286
5 

date its drug testing guidelines to include fentanyl or to issue a report to the Congress that explains its decision not to do so. Based 

on feedback from HHS, CBO estimates that carrying out those activities would require the equivalent of about two employees for 

two years (at an average cost of about $125,000 per employee) and 

additional work from an outside contractor if HHS updated the current guidelines. 

As a result, CBO estimates that implementing the bill would cost 

about $1 million over the 2019–2023 period; such spending would 

be subject to the availability of appropriated amounts. 

Enacting S. 2848 would not affect direct spending or revenues; 

therefore, pay-as-you-go procedures do not apply. 

CBO estimates that enacting S. 2848 would not increase net direct spending or on-budget deficits in any of the four consecutive 

10-year periods beginning in 2029. 

S. 2848 would impose intergovernmental and private-sector mandates as defined in the Unfunded Mandates Reform Act (UMRA) 

by requiring railroads regulated by DOT to expand drug testing to 

include mechanical employees and yardmasters. Because of the relatively small number of these employees and the fact that many 

railroads already test them, CBO expects that the costs of the mandate would be small. 

In addition, the bill would impose a mandate on public and private employers across various transportation sectors regulated by 

DOT if HHS determines that drug testing guidelines should be updated to include fentanyl. In that scenario, the costs of the mandate would be the additional costs employers would incur to test 

their employees for use of fentanyl. According to DOT, approximately 5 million employees—including about 4 million employees 

who have been issued commercial driver’s licenses—would be subject to testing. Under the current testing system, only a fraction 

are randomly tested in any given year. The costs of the mandate 

would vary depending on how many variants of fentanyl HHS 

chooses to include in its guidelines, and also would vary depending 

on the size of each employer. Using information from DOT and 

transportation industry sources, CBO estimates that the costs of 

the mandate could be significant, but would not exceed the annual 

thresholds for intergovernmental and private-sector mandates established in UMRA ($80 million and $160 million in 2018, respectively, adjusted annually for inflation). 

The CBO staff contact for this estimate are Sarah Puro (for DOT 

programs), Andrea Noda (for HHS programs) and Jon Sperl (for 

mandates). The estimate was reviewed by Theresa Gullo, Assistant 

Director for Budget Analysis. 

REGULATORY IMPACT STATEMENT

In accordance with paragraph 11(b) of rule XXVI of the Standing 

Rules of the Senate, the Committee provides the following evaluation of the regulatory impact of the legislation, as reported: 

NUMBER OF PERSONS COVERED

Sections 2 and 3 of S. 2848, as reported, would expand to both 

rail mechanical employees and yardmasters the drug testing requirements applicable to other types of rail employees that have 

6 

16 Bureau of Labor Statistics. National Industry-Specific Occupational Employment and Wage 

Estimates 482100—Rail Transportation. May 2017. (https://www.bls.gov/oes/current/ 

naics4_482100.htm#00-0000) 17DOT. Office of Drug and Alcohol Policy and Compliance. Employees—What are the drug 

& alcohol testing rules and where do I find them?. 2018 (https://www.transportation.gov/odapc/ 

employee). Note that this number includes employees subject to regulations of the United States 

Coast Guard, which is part of the Department of Homeland Security. 

safety responsibilities. The Bureau of Labor Statistics (BLS) estimates that approximately 39,000 yardmasters and conductors and 

approximately 35,000 rail installation, repair, and maintenance 

workers are employed in the United States.16 The majority of employees included in these BLS estimates—including conductors and 

rail signal employees—are already covered under existing DOT 

drug testing requirements, meaning the number of additional persons covered would likely be a small fraction of those 64,000 employees. 

Section 6 of S. 2848 also would require HHS and DOT to include 

fentanyl in the drug testing panel if justified, and section 7 would 

set a deadline for HHS to issue mandatory guidelines on oral fluid 

testing. The promulgation of these guidelines by HHS and subsequent adoption by DOT through rulemaking would affect the approximately 12 million workers performing safety-sensitive transportation occupations in the United States.17 However, the changes 

made are not expected to substantially increase burden on affected 

employees, given that they are already subject to drug testing 

using the existing panel. In fact, both oral fluid and hair testing 

methods are considered to be less invasive and more expedient 

than urine testing. If hair and oral fluid samples become widely 

used in drug testing as a result of HHS’s issuance, cumulative burden on transportation employees could foreseeably be reduced. 

ECONOMIC IMPACT

S. 2848, as reported, is not expected to have a negative impact 

on the Nation’s economy. 

PRIVACY

S. 2848, as reported, is expected to have an impact on the personal privacy of a small number of individuals, since the bill would 

subject rail mechanical employees and yardmasters—currently not 

covered under drug testing requirements unless they perform a 

dual role that otherwise would require testing—to mandatory drug 

testing. With respect to the oral testing provision in section 7, in 

addition to increasing the expediency of testing, this provision is intended to quicken the adoption of an oral sampling method for drug 

testing, which would advance the same objective as urine testing 

with a smaller impact on the privacy of individuals. 

PAPERWORK

S. 2848, as reported, would reduce paperwork requirements for 

regulated entities. Section 9 of the bill would require HHS to approve all certified laboratories requesting use of paperless electronic chain of custody forms used in the course of drug testing. As 

major laboratories responsible for the majority of drug testing in 

the United States transition to completely paperless electronic 

chain of custody systems, the paperwork burden on employers, colVerDate Sep 11 2014 06:41 Jun 28, 2018 Jkt 079010 PO 00000 Frm 00008 Fmt 6659 Sfmt 6602 E:\HR\OC\SR286.XXX SR286
7 

lectors, and laboratories would significantly decrease. In addition, 

section 10 would require FMCSA to provide status reports on its 

implementation of the Commercial Driver’s License Drug and Alcohol Clearinghouse, and section 8 would require HHS to provide status reports on its hair testing guidelines. These two reporting requirements are expected to result in a very small increase in paperwork for those agencies, as necessary for the status reports, up 

until the date of full implementation or compliance with the underlying statutory requirements. 

CONGRESSIONALLY DIRECTED SPENDING

In compliance with paragraph 4(b) of rule XLIV of the Standing 

Rules of the Senate, the Committee provides that no provisions 

contained in the bill, as reported, meet the definition of congressionally directed spending items under the rule. 

SECTION-BY-SECTION ANALYSIS

Section 1. Short title. 

This section would provide that the bill may be cited as the 

‘‘Fighting Opioid Abuse in Transportation Act.’’ 

Section 2. Rail mechanical employee controlled substances and alcohol testing. 

This section would require the Secretary of Transportation to 

publish a final rule to designate rail mechanical employees as employees responsible for safety-sensitive functions for the purposes of 

railroad drug and alcohol testing requirements. In effect, this section would make such requirements applicable to rail mechanical 

employees, similar to other types of railroad employees with safety 

responsibilities, such as engineers or conductors. The section would 

require the Secretary of Transportation to define the term ‘‘rail mechanical employee’’ by regulation. 

Section 3. Rail yardmaster controlled substances and alcohol testing. 

This section would require the Secretary of Transportation to 

publish a final rule to designate yardmasters as employees responsible for safety-sensitive functions for the purpose of railroad drug 

and alcohol testing requirements. In effect, this section would make 

such requirements applicable to yardmasters, similar to other types 

of railroad employees with safety responsibilities, such as engineers 

or conductors. The section would require the Secretary of Transportation to define the term ‘‘yardmaster’’ by regulation. 

Section 4. Department of Transportation public drug and alcohol 

testing database. 

This section would require the Secretary of Transportation to establish and make publicly available on its website a database of 

drug and alcohol testing data reported by employers for each mode 

of transportation and to update the database annually. This section 

would require the database to include, for each mode of transportation, the following: the number of tests by substance tested; results of the tests by substance; the reasons for the tests; and the 

number of individuals who refused testing. This database is inVerDate Sep 11 2014 06:41 Jun 28, 2018 Jkt 079010 PO 00000 Frm 00009 Fmt 6659 Sfmt 6602 E:\HR\OC\SR286.XXX SR286
8 

tended to provide greater transparency of drug and alcohol testing 

data by making it available in a more consolidated and easily accessible format. This section would include protections for commercially sensitive data and for ensuring individual employers and employees are not identified. 

Section 5. GAO report on department of transportation’s collection 

and use of drug testing data. 

This section would require GAO to review DOT’s Drug and Alcohol Testing Information Management System and to submit a report on the review to relevant congressional committees. The report 

would include a description of data collection processes, an assessment of data use, and an assessment of the public database, along 

with potential recommendations for how the management of drug 

and alcohol testing data could be improved. 

Section 6. Transportation workplace drug and alcohol testing program; addition of fentanyl. 

This section would require the Secretary of Health and Human 

Services to determine, within 6 months, whether the inclusion of 

fentanyl on the panel of drugs authorized for testing is justified, 

based on the reliability and cost-effectiveness of available testing. 

If the Secretary does find that the inclusion of fentanyl is justified, 

the agency would be required to issue a revision to the mandatory 

guidelines to include fentanyl on the panel within 18 months of the 

date of the determination. If the Secretary finds that the inclusion 

of fentanyl is not justified, the agency would be required to submit 

a report to Congress explaining, in detail, the reasons for its determination. 

Within 18 months of the Secretary of Health and Human Services publishing the final notice to revise the mandatory guidelines 

to include fentanyl, pursuant to this section, the Secretary of 

Transportation would be required to publish a final rule adding 

fentanyl to DOT’s drug testing panel. 

Section 7. Status reports on hair testing guidelines. 

This section would require the Secretary of Health and Human 

Services to report to Congress on the status of the final notice for 

the statutorily-required scientific and technical guidelines for hair 

testing, within 30 days of enactment of this bill and every 6 

months thereafter, until the agency publishes a final notice of 

guidelines for hair testing. The section would require the report to 

include the following: an explanation of why the guidelines have 

not been issued; a schedule, including benchmarks, for the completion of the guidelines; and an estimated date of completion for the 

guidelines. The section would include a provision to address positive test results, of the individual being tested, caused solely by the 

drug use of others and not caused by the drug use of the individual 

being tested. 

In addition, the Committee directs HHS to conduct, every 60 

days starting from the date of enactment of this bill and until the 

issuance of the final notice of guidelines for hair testing, staff-level 

briefings with the Committee on Commerce, Science, and Transportation of the Senate and the Committee on Transportation and Infrastructure of the House of Representatives. The briefings should 

9 

include an explanation of why the guidelines have not been issued; 

a schedule, including benchmarks, for the completion of the guidelines; and an estimated date of completion for the guidelines. 

Section 8. Mandatory guidelines for Federal workplace drug testing 

programs using oral fluid. 

This section would require the Secretary of Health and Human 

Services to publish a final notice of mandatory guidelines for oral 

fluid testing not later than December 31, 2018, based on the notice 

of proposed mandatory guidelines published in 2015. The section 

would include a provision to address positive test results, of the individual being tested, caused solely by the drug use of others and 

not caused by the drug use of the individual being tested. 

Section 9. Electronic recordkeeping. 

This section would require the Secretary of Health and Human 

Services, not later than 1 year from the date of enactment of this 

bill, to ensure each certified laboratory that requests the use of 

paperless electronic chain of custody forms receives approval. This 

section also would require the Secretary of Transportation, not 

later than 30 months from the date of enactment of this bill, to 

issue a final rule authorizing the use of electronic signatures for all 

paperless chain of custody forms under part 40 of title 49, Code of 

Federal Regulations. 

Section 10. Status reports on Commercial Driver’s License Drug and 

Alcohol Clearinghouse. 

This section would require FMCSA to submit a report to Congress biannually on the implementation of the final rule for the 

Commercial Driver’s Drug and Alcohol Clearinghouse, until such 

rule is fully implemented. The report would include an updated 

schedule for implementation of the rule as soon as practicable and 

a description of actions taken by FMCSA to implement the rule before the compliance date of January 6, 2020. 

CHANGES IN EXISTING LAW

In compliance with paragraph 12 of rule XXVI of the Standing 

Rules of the Senate, the Committee states that the bill as reported 

would make no change to existing law. 

Æ